Versant Capital Management, Inc United Therapeutics Corp Transaction History
Versant Capital Management, Inc
- $637 Million
- Q2 2025
A detailed history of Versant Capital Management, Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Versant Capital Management, Inc holds 31 shares of UTHR stock, worth $9,002. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 53
41.51%
Holding current value
$9,002
Previous $16,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.6MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.29 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$777 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$648 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$612 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...